MARCHEX INC — Form 8-K
Filed August 12, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
Marchex completed its acquisition of Archenia on July 1, 2026 (closing date; the deal was previously announced). Marchex's standalone Q2 2026 revenue was $11.0M vs. $11.7M in Q2 2025 (down 6%). On a pro forma combined basis (including Archenia for full Q2), combined revenue was $15.5M with adjusted EBITDA of $1.0M before $1.0M in reorganization costs ($2.0M adjusted EBITDA after adding back those costs). Management guided Q3 2026 pro forma combined revenue to $16.0–$16.5M and adjusted EBITDA (net of reorganization costs) to $2.3–$2.5M. Early customer adoption of combined products is cited as encouraging; three customer examples show revenue uplift from bundled offerings.
Why this rating
Acquisition materially expands revenue base (~40% pro forma) and product scope; early upsell traction validates strategy. Meaningful relative to $74M market cap but integration risks and standalone revenue decline offset gains.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.